North Tide Capital as of March 31, 2014
Portfolio Holdings for North Tide Capital
North Tide Capital holds 24 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Select Medical Holdings Corporation (SEM) | 14.6 | $174M | 14M | 12.45 | |
| Teva Pharmaceutical Industries (TEVA) | 13.3 | $159M | 3.0M | 52.84 | |
| Allergan | 7.3 | $87M | 700k | 124.10 | |
| WellPoint | 7.1 | $85M | 850k | 99.55 | |
| Actavis | 6.9 | $82M | 400k | 205.85 | |
| WellCare Health Plans | 6.7 | $79M | 1.3M | 63.52 | |
| Healthways | 5.6 | $66M | 3.9M | 17.14 | |
| Quest Diagnostics Incorporated (DGX) | 4.9 | $58M | 1.0M | 57.92 | |
| NuVasive | 4.8 | $58M | 1.5M | 38.41 | |
| Amedisys (AMED) | 4.0 | $48M | 3.2M | 14.89 | |
| Kindred Healthcare | 3.0 | $35M | 1.5M | 23.42 | |
| Myriad Genetics (MYGN) | 2.9 | $34M | 1.0M | 34.19 | |
| Orthofix International Nv Com Stk | 2.9 | $34M | 1.1M | 30.15 | |
| Syneron Medical Ltd ord | 2.6 | $31M | 2.5M | 12.45 | |
| Magellan Health Services | 2.5 | $30M | 500k | 59.35 | |
| Mylan | 2.1 | $24M | 500k | 48.83 | |
| Boston Scientific Corporation (BSX) | 1.8 | $22M | 1.6M | 13.52 | |
| Almost Family | 1.8 | $22M | 930k | 23.10 | |
| Community Health Systems (CYH) | 1.6 | $20M | 500k | 39.17 | |
| ACCRETIVE Health | 1.4 | $16M | 2.0M | 8.00 | |
| Supervalu | 1.1 | $14M | 2.0M | 6.84 | |
| Accuray Incorporated (ARAY) | 0.4 | $4.8M | 500k | 9.60 | |
| Gentiva Health Services | 0.4 | $4.6M | 500k | 9.12 | |
| Genomic Health | 0.2 | $2.6M | 100k | 26.34 |
